Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication

Renal cell tumors (RCTs) are the most lethal of the common urological cancers. The widespread use of imaging entailed an increased detection of small renal masses, emphasizing the need for accurate distinction between benign and malignant RCTs, which is critical for adequate therapeutic management....

ver descrição completa

Detalhes bibliográficos
Autor principal: Pires-Luís, Ana Sílvia (author)
Outros Autores: Vieira-Coimbra, Marcia (author), Quintela Vieira, Ana Filipa (author), Costa-Pinheiro, Pedro (author), Silva-Santos, Rui (author), Dias, Paula C (author), Antunes, Luís (author), Lobo, Francisco (author), Oliveira, Jorge (author), Gonçalves, Céline S (author), Costa, Bruno M (author), Henrique, Rui (author), Jerónimo, Carmen (author)
Formato: article
Idioma:eng
Publicado em: 2019
Assuntos:
Biomarkers, Tumor
Carcinoma, Renal Cell
Chromosomal Proteins, Non-Histone
Diagnosis, Differential
Early Detection of Cancer
Gene Expression Regulation, Neoplastic
Histone Demethylases
Histone-Lysine N-Methyltransferase
Kidney Neoplasms
Prognosis
Up-Regulation
Texto completo:http://hdl.handle.net/10400.22/14164
País:Portugal
Oai:oai:recipp.ipp.pt:10400.22/14164

Texto Completo

http://hdl.handle.net/10400.22/14164

Registos relacionados